Zycubo is a copper replacement therapy administered via subcutaneous injection to bypass impaired GI absorption in patients with Menkes disease.
Gilead Sciences, Inc. (Nasdaq: GILD) today announced The New England Journal of Medicine (NEJM) published the full results from the positive Phase 3 ASCENT-04/KEYNOTE-D19 study evaluating the ...
SCU is committed to empowering our students to practice safer substance usage and to be prepared to administer potentially life-saving Naloxone to someone in need. Under California law AB-635, “Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results